Bioorganic & Medicinal Chemistry Letters 10 (2000) 979±981
ꢀ-Carbonyl Substituted Glutathione Conjugates as Inhibitors
of O. Volvulus GST2
a
a
b
Peter M. Brophy, Alison M. Campbell, Annamaria J. van Eldik,
b
b,
c
Paul H. Teesdale-Spittle, * Eva Liebau and Meng F. Wang
aInstitute of Biological Sciences, University of Wales, Aberystwyth, Ceredigion SY23 3DA, UK
bDepartment of Chemistry, De Montfort University, The Gateway, Leicester LE1 9BH, UK
cBernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Str 74, Hamburg, Germany
Received 16 November 1999; accepted 28 February 2000
AbstractÐA series of b-carbonyl substituted glutathione conjugates were prepared and evaluated as inhibitors of OvGST2. Their
speci®city for the parasite derived protein was assessed through comparison with their inhibition of human pGST. Inhibition of
OvGST2 has been demonstrated at low micromolar concentrations for these conjugates and selectivity for OvGST2 over human p-
GST of greater than 10-fold has been achieved. # 2000 Elsevier Science Ltd. All rights reserved.
Introduction
contract, the glutathione binding site is closely related to
that found in the mammalian enzymes: Notably the Tyr
115 residue is almost identically placed in both the mam-
malian and parasite enzymes. This residue is a potential
target for binding of a number of p-GST inhibitors, all
bearing a carbonyl moiety b to the point of where glu-
tathione conjugation occurs.5
The ®larial nematode parasite Onchocerca volvulus causes
onchocerciasis; a major cause of preventable blindness and
severe dermatitis in Africa. Glutathione S-transferases
(
GSTs) are the linchpin of parasitic helminth defence
,6
mechanisms, providing their major phase II detoxi®ca-
tion system and accounting for up to 4% of the total
soluble protein. Two O. volvulus GSTs have been repor-
ted to date, OvGST1 and OvGST2. We have previously
reported the isolation of puri®ed active recombinant
OvGST2. GSTs detoxify electrophilic compounds,2
including many anthelmintics and cytotoxins arising
Given the signi®cant divergence from host GSTs, we
propose that selective inhibition of parasite derived
GST enzymes is a realisable chemotherapeutic target.
This should ultimately tip the molecular balance in
favour of the host during the characteristically chronic
nematode infection and may be an important adjunct in
1
3
from the eector mechanism of the immune response,
through catalysis of their conjugation to glutathione.
3
eective immuno- and chemotherapy. Selective inhibi-
tors of nematode GST will also provide new tools to
study host±parasite interactions.
Unlike mammalian GSTs, parasitic nematode GSTs are
not well characterised. Biochemical, immunological and
primary amino acid sequence analysis fails to place
OvGST2 into any of the ®ve characterised mammalian
species independent soluble GST families (a, m, p, y and
s). Homology models indicate critical structural dier-
ences at the active site between host and parasite
enzymes. In particular, the parasitic enzymes, whilst
strongly topologically related to the mammalian p-GST4
family, have a very open hydrophobic binding cleft.
This is in contrast to that found in the mammalian
enzymes, which have a more constricted feature. By
It is our hypothesis that suitable derivatisation of b-keto
substituted glutathione S-conjugates will engender speci-
®city along with established abolition of target enzyme
activity. As part of our ongoing investigations into the
utility of GSTs as a target for antiparasitic agents, we have
synthesised a series of b-carbonyl substituted glutathione
conjugates as inhibitors of OvGST2.
Chemistry
Enones were synthesized by the base catalysed Aldol con-
densation and the a,b -unsaturated esters were synthesized
*
7
Corresponding author. Tel.: +44-116-257-7115; fax: +44-116-257-
0960-894X/00/$ - see front matter # 2000 Elsevier Science Ltd. All rights reserved.
PII: S0960-894X(00)00142-6